Ginkgo Bioworks Unveils Innovative ADME Profiling Services
Ginkgo Bioworks has recently launched an exciting and cost-effective high-throughput ADME (Absorption, Distribution, Metabolism, and Excretion) profiling service. This groundbreaking initiative aims to enhance small molecule drug discovery by delivering model-ready datasets with remarkable speed.
By leveraging Ginkgo's proprietary RAC automation, this service makes it possible for researchers to access essential ADME data at an unmatched efficiency level. Notably, Ginkgo Bioworks ensures that all of its operations are based in the United States, allowing for an agile response to the needs of the ongoing drug development processes.
This new offering not only stands out due to its affordability but also promises to significantly reduce risks in the drug development pipeline for small molecules. With Ginkgo Datapoints, researchers will now have powerful tools at their disposal, making it easier than ever to prioritize drug candidates and utilize this data for training advanced predictive models.
Jason Kelly, co-founder and CEO of Ginkgo Bioworks, expressed excitement about the launch, stating: "We are thrilled to introduce our new ADME service, which we believe will be a game-changer for drug discovery. We aim to match or beat any quote received from international vendors while ensuring that our foundational pricing reflects best-in-class quality. We leverage our scale and automation to deliver on this promise."
Key Features of the ADME Profiling Service
This new service is designed with multiple features aimed at enhancing the drug discovery process:
Scalable Automated Workflows
Ginkgo’s ADME profiling service includes scalable, automated workflows that represent the company’s standard in laboratory automation. This innovation drastically reduces manual labor and enables researchers to focus on more crucial analytical tasks.
Cost-Effective Pricing
The pricing model is built specifically for throughput. Ginkgo Bioworks guarantees that its pricing will remain competitive against quotes from Chinese and other international vendors, ensuring clients receive the best value without compromising quality.
Rapid Turnaround Time
Understanding the fast-paced demands of modern drug discovery, Ginkgo emphasizes rapid response times, ensuring researchers receive the data they need to make informed decisions swiftly.
Model-Ready Datasets
The datasets generated through this service are enriched with structured metadata, making them ideal for AI-powered insights. This enables seamless integration into machine learning applications, advancing the potential for innovations in drug discovery.
The Future of Biology with Ginkgo Bioworks
With its ground-breaking ADME profiling service, Ginkgo Bioworks is setting new standards in the biopharmaceutical industry. By making biology easier to engineer, Ginkgo Bioworks empowers scientists. Their innovative laboratory automation solutions allow experts to concentrate on analyzing and planning experiments, significantly enhancing operational efficiency.
In addition, Ginkgo Datapoints employs state-of-the-art automation to produce extensive laboratory datasets that can energize AI model development. This is aligned with Ginkgo's broader mission of leveraging biology to address modern challenges.
More than Just a Laboratory
Beyond Ginkgo's automation and profiling services, Ginkgo Biosecurity is committed to developing innovative infrastructure and technologies that global leaders require. Their work focuses on effectively predicting, identifying, and mitigating various biological threats.
Frequently Asked Questions
What is the new ADME profiling service from Ginkgo Bioworks?
The ADME profiling service is a high-throughput, cost-effective offering designed to support small molecule drug discovery through efficient data generation.
How does Ginkgo Bioworks ensure competitive pricing?
Ginkgo Bioworks offers a price match guarantee against quotes from international vendors, aiming to provide superior pricing and service.
What are the benefits of the ADME service?
The service delivers rapid turnaround times, scalable workflows, and model-ready datasets that enhance efficiency and predictive modeling in drug discovery.
Who is behind Ginkgo Bioworks?
Ginkgo Bioworks was co-founded by Jason Kelly, who serves as the CEO, guiding the company towards innovations in cell programming and biopharma solutions.
What sets Ginkgo apart from traditional laboratories?
Ginkgo's unique combination of automation, scalability, and focus on data-rich outputs positions it ahead of traditional labs in facilitating rapid biopharma advancements.
